Insider · CIK 0001313397

Rodgers Richard J

Reports to the SEC for 7 companies · GAITHERSBURG, MD

sec.gov

Transactions

Companies

Filings

CIK

0001313397

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-20	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−18.9K sh	—	—	0
2026-06-20	NVAXNOVAVAX INCM Exercise/Conversion	Director	MExercise/Conversion	+18.9K sh	—	—	47,370
2026-06-18	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	Director	AAward	+14.2K sh	—	—	14,180
2026-06-18	NVAXNOVAVAX INC · Stock Option (Right to Buy)A Award	Director	AAward	+21.3K sh	—	—	21,270
2026-06-16	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+39.7K sh	—	—	39,715
2026-06-16	ARDXARDELYX, INC.A Award	Director	AAward	+26.5K sh	—	—	439,998
2026-04-20	IRDOpus Genetics, Inc.A Award	Director	AAward	+24.4K sh	—	—	343,022
2025-10-29	NVAXNOVAVAX INCM Exercise/Conversion	Director	MExercise/Conversion	+3,800 sh	—	—	28,490
2025-10-29	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,800 sh	—	—	0
2025-06-20	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	Director	AAward	+18.9K sh	—	—	18,884
2025-06-20	NVAXNOVAVAX INC · Stock Option (Right to Buy)A Award	Director	AAward	+28.3K sh	$6.42	+$182K	28,326
2025-06-18	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+54.1K sh	—	—	54,059
2025-06-18	ARDXARDELYX, INC.A Award	Director	AAward	+41.6K sh	—	—	413,543
2025-06-18	ARDXARDELYX, INC.A Award	Director	AAward	+21.5K sh	—	—	371,992
2025-06-12	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−10.4K sh	—	—	0
2025-06-12	NVAXNOVAVAX INCM Exercise/Conversion	Director	MExercise/Conversion	+10.4K sh	—	—	24,690
2025-04-30	IRDOpus Genetics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+79.6K sh	—	—	79,592
2025-04-30	IRDOpus Genetics, Inc.A Award	Director	AAward	+79.5K sh	—	—	318,655
2025-01-16	ARDXARDELYX, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−100K sh	—	—	0
2025-01-16	ARDXARDELYX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+100K sh	$0.55	+$55K	350,524
2024-10-29	NVAXNOVAVAX INCM Exercise/Conversion	Director	MExercise/Conversion	+3,800 sh	—	—	14,270
2024-10-29	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,800 sh	—	—	3,800
2024-06-14	ARDXARDELYX, INC.A Award	Director	AAward	+12.2K sh	—	—	250,524
2024-06-14	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+40.2K sh	—	—	40,243
2024-06-12	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,670 sh	—	—	0
2024-06-12	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	Director	AAward	+10.4K sh	—	—	10,420
2024-06-12	NVAXNOVAVAX INC · Stock Option (Right to Buy)A Award	Director	AAward	+15.6K sh	$15.86	+$248K	15,630
2024-06-12	NVAXNOVAVAX INCM Exercise/Conversion	Director	MExercise/Conversion	+6,670 sh	—	—	10,470
2024-06-11	IRDOpus Genetics, Inc.A Award	Director	AAward	+41.1K sh	—	—	239,151
2024-06-11	IRDOpus Genetics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35.2K sh	—	—	35,181
2024-01-01	IRDOpus Genetics, Inc.A Award	Director	AAward	+24.8K sh	—	—	198,008
2023-11-01	IRDOpus Genetics, Inc.A Award	Director	AAward	+35K sh	—	—	173,246
2023-10-29	NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,800 sh	—	—	7,600
2023-10-29	NVAXNOVAVAX INCM Exercise/Conversion	Director	MExercise/Conversion	+3,800 sh	—	—	3,800
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,976 sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.8K sh	—	—	23,839
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.8K sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.2K sh	—	—	23,216
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.2K sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,976 sh	—	—	1,976
2023-06-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+49.2K sh	—	—	49,237
2023-06-15	ARDXARDELYX, INC.A Award	Director	AAward	+18.5K sh	—	—	238,320
2023-06-12	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	Director	AAward	+6,670 sh	—	—	6,670
2023-06-12	NVAXNOVAVAX INC · Stock Option (Right to Buy)A Award	Director	AAward	+7,710 sh	—	—	7,710
2023-04-19	IRDOpus Genetics, Inc.A Award	Director	AAward	+50K sh	—	—	138,246
2023-01-11	IRDOpus Genetics, Inc.A Award	Director	AAward	+20.8K sh	—	—	88,246
2022-10-29	NVAXNOVAVAX INC · Restricted Stock UnitsA Award	Director	AAward	+11.4K sh	—	—	11,400
2022-10-29	NVAXNOVAVAX INC · Stock Option (Right to buy)A Award	Director	AAward	+17.1K sh	—	—	17,095
2022-10-03	IRDOpus Genetics, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+3,148 sh	$0.00	+$0.315	67,424
2022-10-03	IRDOpus Genetics, Inc. · Series B Warrant (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−3,148 sh	—	—	0

Recent filings

Accepted (ET)
Jun 234
Rodgers Richard J0001104659-26-076930
SEC(opens sec.gov)
Jun 184
Rodgers Richard J0001313397-26-000002
SEC(opens sec.gov)
Apr 224
Rodgers Richard J0000905148-26-001788
SEC(opens sec.gov)
Oct 304
Rodgers Richard J0001104659-25-104413
SEC(opens sec.gov)
Jun 244
Rodgers Richard J0001104659-25-062196
SEC(opens sec.gov)
Jun 234
Rodgers Richard J0001628280-25-032729
SEC(opens sec.gov)
Jun 134
Rodgers Richard J0001593968-25-000759
SEC(opens sec.gov)
May 24
Rodgers Richard J0000905148-25-001430
SEC(opens sec.gov)
Jan 174
Rodgers Richard J0001628280-25-001849
SEC(opens sec.gov)

Companies

Address

21 FIRSTFIELD ROAD

GAITHERSBURG, MD, 20878